A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. - Concepedia

Concepedia

Publication | Closed Access

A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.

21

Citations

19

References

2012

Year

Hanna Czajka, Serhat Ünal, Sercan Ulusoy, Gaye Usluer, Adam Strus, Engın Sennaroğlu, Justyna Guzik, Arzu Topeli̇, A Dargiewicz, Diego Castro Musial,

Abstract

These data demonstrate that a low antigen dose in combination with MF59 adjuvant is adequate for the routine pre-pandemic immunization of adult and elderly subjects.

References

	Year	Citations

Page 1